10/12/2018Digital therapeutics and healthcare innovationOverview Digital technology is transforming the way that healthcare is practiced and delivered, with areas like digital therapeutics Share XDigital therapeutics and healthcare innovationhttps://pharmaphorum.com/debates-insight-digital/digital-therapeutics-and-healthcare-innovation/
Parenting as a DMD patientParenting as a DMD patient The sleepless nights and steep learning curve that will be familiar to any Share XParenting as a DMD patienthttps://pharmaphorum.com/views-analysis-digital/parenting-as-a-dmd-patient/
The NHS and integrated care systems – how can pharma play its part?The concept of joining up health and social care has been around a long time – but now Share XThe NHS and integrated care systems – how can pharma play its part?https://pharmaphorum.com/views-analysis-market-access/nhs-integrated-care-systems/
The changing face of pharmaceutical launchesThe industry has experienced a sustained period of change since its blockbuster heyday in the 1990s and continues Share XThe changing face of pharmaceutical launcheshttps://pharmaphorum.com/market-access-2/digital-transforming-pharmaceutical-launches/
FDA approves Janssen’s HIV combination SymtuzaJanssen has won US approval for its once-daily HIV pill Symtuza (D/C/F/TAF), which it hopes will improve patient Share XFDA approves Janssen’s HIV combination Symtuzahttps://pharmaphorum.com/news/fda-janssen-hiv-symtuza/
Otsuka has high hopes for its ‘drug creation engine’ acquisitionOtsuka is paying $430 million for a US clinical-stage biotech company it hopes will act as a ‘drug Share XOtsuka has high hopes for its ‘drug creation engine’ acquisitionhttps://pharmaphorum.com/news/otsuka-biotech-visterra-hierotope/
Marketing science – brand innovation for pharmaCombining fields such as economics, statistics and operations research, marketing science has for some time operated under-the-radar as Share XMarketing science – brand innovation for pharmahttps://pharmaphorum.com/debates-insight-sales-marketing/marketing-science-brand-innovation-for-pharma/
Was pharma bold enough at Lions Health 2018?The Lions Health 2018 jury brought 10 senior communications executives together in Cannes, with representatives from China, Australia, Share XWas pharma bold enough at Lions Health 2018?https://pharmaphorum.com/views-analysis-sales-marketing/pharma-bold-cannes-lions-health-2018/
He ain’t heavy – learning about a sibling’s DMD diagnosisIt’s common for patients to want to know more about what’s causing them to be ill and their Share XHe ain’t heavy – learning about a sibling’s DMD diagnosishttps://pharmaphorum.com/views-and-analysis/learning-sibling-dmd-diagnosis/
